pubmed-article:1822132 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0036572 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C1096063 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0728940 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0015252 | lld:lifeskim |
pubmed-article:1822132 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:1822132 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1822132 | pubmed:dateCreated | 1992-9-2 | lld:pubmed |
pubmed-article:1822132 | pubmed:abstractText | Children harboring hemispheric tumors associated with intractable epilepsy were retrospectively reviewed to assess seizure outcome following tumor resection and electrocorticography-guided seizure foci removal. Thirteen (93%) of our patients have remained seizure-free, off anticonvulsants or on tapering doses, following surgery with a mean follow-up of 33 months. Fifteen of 16 (93%) seizure foci examined histologically were void of tumor infiltration. A review of the literature is provided regarding the controversy of tumor removal versus additional seizure foci removal at the time of tumor removal in providing optimal seizure control. | lld:pubmed |
pubmed-article:1822132 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1822132 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1822132 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1822132 | pubmed:language | eng | lld:pubmed |
pubmed-article:1822132 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1822132 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1822132 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1822132 | pubmed:issn | 1016-2291 | lld:pubmed |
pubmed-article:1822132 | pubmed:author | pubmed-author:OjemannG AGA | lld:pubmed |
pubmed-article:1822132 | pubmed:author | pubmed-author:GhatanSS | lld:pubmed |
pubmed-article:1822132 | pubmed:author | pubmed-author:BergerM SMS | lld:pubmed |
pubmed-article:1822132 | pubmed:author | pubmed-author:KelesG EGE | lld:pubmed |
pubmed-article:1822132 | pubmed:author | pubmed-author:GeyerJ RJR | lld:pubmed |
pubmed-article:1822132 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1822132 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:1822132 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1822132 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1822132 | pubmed:pagination | 185-91 | lld:pubmed |
pubmed-article:1822132 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:meshHeading | pubmed-meshheading:1822132-... | lld:pubmed |
pubmed-article:1822132 | pubmed:articleTitle | Seizure outcome in children with hemispheric tumors and associated intractable epilepsy: the role of tumor removal combined with seizure foci resection. | lld:pubmed |
pubmed-article:1822132 | pubmed:affiliation | University of Washington Medical Center, Seattle. | lld:pubmed |
pubmed-article:1822132 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1822132 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:1822132 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:1822132 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |